Brought to you by 
DFB Pharmaceuticals buys IsoTis's wound management business
03 Jun 2011
Executive Summary
DFB Pharmaceuticals' Healthpoint Ltd. division (wound care and surgical products) bought bone graft specialist IsoTis OrthoBiologics' wound management business EpiSource SA.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Biomaterials
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
DFB Pharmaceuticals buys IsoTis's wound management business
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice